- Home
- CRIS vs CENN Comparison
CRIS vs CENN Comparison
Compare CRIS & CENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- CENN
- Stock Information
- Founded
- CRIS 2000
- CENN 2013
- Country
- CRIS United States
- CENN United States
- Employees
- CRIS N/A
- CENN N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- CENN Auto Manufacturing
- Sector
- CRIS Health Care
- CENN Consumer Discretionary
- Exchange
- CRIS Nasdaq
- CENN Nasdaq
- Market Cap
- CRIS 21.3M
- CENN 30.4M
- IPO Year
- CRIS 2000
- CENN N/A
- Fundamental
- Price
- CRIS $1.75
- CENN $0.70
- Analyst Decision
- CRIS Strong Buy
- CENN
- Analyst Count
- CRIS 2
- CENN 0
- Target Price
- CRIS $16.50
- CENN N/A
- AVG Volume (30 Days)
- CRIS 128.9K
- CENN 331.3K
- Earning Date
- CRIS 07-31-2025
- CENN 08-12-2025
- Dividend Yield
- CRIS N/A
- CENN N/A
- EPS Growth
- CRIS N/A
- CENN N/A
- EPS
- CRIS N/A
- CENN N/A
- Revenue
- CRIS $11,202,000.00
- CENN $31,097,533.00
- Revenue This Year
- CRIS N/A
- CENN N/A
- Revenue Next Year
- CRIS $10.67
- CENN N/A
- P/E Ratio
- CRIS N/A
- CENN N/A
- Revenue Growth
- CRIS 14.17
- CENN 234.45
- 52 Week Low
- CRIS $1.02
- CENN $0.64
- 52 Week High
- CRIS $8.29
- CENN $1.84
- Technical
- Relative Strength Index (RSI)
- CRIS 34.36
- CENN 39.67
- Support Level
- CRIS $2.11
- CENN $0.66
- Resistance Level
- CRIS $2.48
- CENN $0.79
- Average True Range (ATR)
- CRIS 0.21
- CENN 0.09
- MACD
- CRIS -0.06
- CENN -0.03
- Stochastic Oscillator
- CRIS 17.36
- CENN 11.81
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About CENN Cenntro Electric Group Limited
Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.